These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28240527)

  • 21. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies.
    Gu D; Wang M; Zhang Z; Chen J
    Breast Cancer Res Treat; 2010 Jul; 122(2):527-31. PubMed ID: 20054639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The OGG1 Ser326Cys polymorphism and the risk of esophageal cancer: a meta-analysis.
    Wang Z; Gan L; Nie W; Geng Y
    Genet Test Mol Biomarkers; 2013 Oct; 17(10):780-5. PubMed ID: 23909557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of hOGG1 Ser326Cys polymorphism with colorectal cancer risk: an updated meta-analysis including 5235 cases and 8438 controls.
    Zhang M; Mo R
    Tumour Biol; 2014 Dec; 35(12):12627-33. PubMed ID: 25227662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Meta analysis of association between Ser326Cys polymorphism of hOGG1 gene and risk of lung cancer].
    Qian Q; Liu R; Lei Z; You J; Zhou Q; Zhang HT
    Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):205-10. PubMed ID: 21426661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between the hOGG1 Ser326Cys polymorphism and gastric cancer risk: a meta-analysis.
    Li BR; Zhou GW; Bian Q; Song B
    Asian Pac J Cancer Prev; 2012; 13(4):1145-9. PubMed ID: 22799296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.
    Zhang H; Xu Y; Zhang Z; Li L
    BMC Cancer; 2011 Sep; 11():391. PubMed ID: 21914193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk: evidence from 1180 cases and 2444 controls.
    Ni M; Qiu J; He W; Wang X
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):683-7. PubMed ID: 22343785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.
    Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z
    Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of hOGG1 Ser326Cys polymorphism with gastric cancer risk: a meta-analysis.
    Niu Y; Li F; Tang B; Shi Y; Yu P
    Mol Biol Rep; 2012 Jun; 39(6):6563-8. PubMed ID: 22294108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls.
    Guan P; Huang D; Yin Z; Zhou B
    Asian Pac J Cancer Prev; 2011; 12(4):1067-72. PubMed ID: 21790253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic association between hOGG1 C8069G polymorphism and colorectal cancer risk.
    Sun X; Yang H; Lin Y; Zhao J; Bao Y; Liu X; Qi Z; Wang S; Huang C; Yu Z
    Int J Clin Exp Med; 2015; 8(11):21145-51. PubMed ID: 26885047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of the hOGG1 Ser326Cys polymorphism using LightCycler technology.
    Rihs HP; Marczynski B; Rabstein S; Scherenberg M; Landt O; Bruning T
    J Toxicol Environ Health A; 2008; 71(13-14):877-80. PubMed ID: 18569589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung Cancer Susceptibility and hOGG1 Ser326Cys Polymorphism: A Meta-Analysis.
    Kiyohara C; Takayama K; Nakanishi Y
    Cancers (Basel); 2010 Oct; 2(4):1813-29. PubMed ID: 24281202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of miR-146a rs2910164 polymorphism with squamous cell carcinoma risk: a meta-analysis.
    Zhang X; He R; Ren F; Tang R; Chen G
    J BUON; 2015; 20(3):829-41. PubMed ID: 26214637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the association between hOGG1 C8069G polymorphism and colorectal cancer.
    Lu M; Sun L; Zhou J; Zhang J
    Tumour Biol; 2014 Mar; 35(3):2373-7. PubMed ID: 24297334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cumulative meta-analysis and trial sequential analysis of correlation between hOGG1 Ser326Cys polymorphism and the risk of head and neck squamous cell carcinoma.
    Yan Y; Deng AP; Chen W; Ming YH; Zeng XT; Leng WD
    Oncotarget; 2018 Feb; 9(16):13077-13087. PubMed ID: 29560133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
    Li H; Hao X; Zhang W; Wei Q; Chen K
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.
    Tang W; Chen Y; Wang Y; Gu H; Chen S; Kang M
    Int J Clin Exp Med; 2015; 8(8):12226-38. PubMed ID: 26550133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between OGG1 Ser326Cys polymorphism and risk of upper aero-digestive tract and gastrointestinal cancers: a meta-analysis.
    Das S; Nath S; Bhowmik A; Ghosh SK; Choudhury Y
    Springerplus; 2016; 5():227. PubMed ID: 27026921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hOGG1 C1245G gene polymorphism associated with prostate cancer: a meta-analysis.
    Chen Y; Li J; Li T; Mo Z
    Int J Biol Markers; 2015 May; 30(2):e161-8. PubMed ID: 25907663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.